参考文献

1.彭向欣，王泰龄.肝脏疾病临床病理学.北京：化学工业出版社，2010

2.邹仲之.组织学与胚胎学.第6版.北京：人民卫生出版社，2006

3.陈灏珠.实用内科学.第11版.北京：人民卫生出版社，2002

4.Guo W，Crossey EL，Zhang L，et al.Alcohol Exposure Decreases CREB Binding Protein Expression and Histone Acetylation in the Developing Cerebellum.PLOS ONE，2011，6： e19351

5.Maurage P，Callot C，Chang B，et al.Olfactory Impairment Is Correlated with Confabulation in Alcoholism： Towards a Multimodal Testing of Orbitofrontal Cortex.PLOS ONE，2011，6： e23190

6.Rosen A，Kuilenburg A，Borkhardt K.Severe Encephalopathy，Lactic Acidosis，Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment～Pyrimidine Degradation Defect or Beriberi.Case Reports in Oncology，2011，4： 371-376

7.Du łak E，Lubiński A，Bissinger A，et al.Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy： evidence-based predictors.Original article，2009，67： 8

8.Fogle RL，Hollenbeak CS，Stanley BA，et al.Functional proteomic analysis reveals sex-dependent differences in structural and energy-producing myocardial prot eins in rat model of alcoholic cardiomyopathy.Articles in Press.Physiol Genomics，2011，10： 1152

9.Happel KI，Rudner X，Quinton LJ，et al.Acute alcohol intoxication suppresses the pulmonary ELR-negative CXC chemokine response to lipopolysaccharide.Alcohol，2007，41（5）：325-333

10.Brown LA，Ping XD，Harris FL，et al.Glutathione availability modulates alveolar macrophage functions in the chronic ethanol-fed rat.Am J Physiol Lung Cell Mol Physiol，2007.292（4）：L824-L832

11.Polikandriotis JA，Rupnow HL，Elms SC，et al.Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung.Am J Respir Cell Mol Biol，2006，34（3）：314-319

12.Das SK，Vasudevan DM.Essential factors associated with hepatic angiogenesis.Life Sciences 2007，81（23/24）：177-187

13.Bumham EL，Halkar，R，Burks M，et al.The effects of alcohol abuse on pulmonary alveolarcapillary barrier function in humans.Alcohol Alcoholism，2009，44（1）：8-12

14.Joseph H，Siison MD.Alcohol and airways function in health and disease.Alcohol，2007，41（5）：293-07

15.Heinemann HO.Alcohol and the lung.A brief review.Am J Med，1977，63：81-85

16.Happel KI，Nelson S.Alcohol，immunosuppression and the lung.Proc Am Thorac Soc，2005，2：428-432

17.Forget MA，Sisson JH，Spurzem JR，et al.Ethanol increases phosphodiesterase 4 activity in bovine bronchial epithelial cells.Alcohol，2003，31：31-38

18.Antonicelli L，Micucci C，Bonifazi F.Is ethanol-induced bronchos-pasm an inflammation-driven event.Allergy，2006，61（2）：270-271

19.Trevisani M，Gazzieri D，Benvenuti F，et al.Ethanol causes inflammation in the airways by a neurogenic and TRPV1-dependent mechanism.J Pharmacol Exp Ther，2004，309（3）：1167-1173

20.Bechara RI，Brown LAS，Roman J，et al.Transforming growth factor 1 expression and activation is increased in the alcoholic rat lung.Am J Respir Crit Care Med，2004，170：188-194

21.Jones SG，Morrisey K，Williams JD，et al.TGF-betal stimulates the release of pre-formed bFGF from renal proximal tubular cells.Kidney Int，1999，56（1）：83-91

22.Femandez AL，Koval M，Fan X，et al.Chronic alcohol ingestion alters claudin espression in the alveolar epithelium of rats.Alcohol，2007，41（5）：371-379

23.Burnham EL，Halkar R，Burks M，et al.The effects of alcohol abuse on pulmonary alveolarcapillary barrier function in humans.Alcohol Alcoholism，2009，44（1）：8-12

24.Francque SM，Verrijken A，Mertens I，et al.Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients.Clin Gastroenterol Hepatol，2012，10（10）：1162-1168

25.Verma S，Jensen D，Hart J，et al.Predictive value of ALT levels for non-alcoholic steatohepatitis（NASH）and advanced fibrosis in non-alcoholic fatty liver disease（NAFLD）.Liver Int，2013，33（9）：1398-1405

26.Kwok R，Tse YK，Wong GL，et al.Systematic review with meta-analysis： non-invasive assessment of non-alcoholic fatty liver disease-the role of transient elastography and plasma cytokeratin-18 fragments.Aliment Pharmacol Ther，2014，39（3）：254-269

27.Festi D，Schiumerini R，Marzi L，et al.Review article： the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods.Aliment Pharmacol Ther，2013，37（4）：392-400

28.Cusi K，Chang Z，Harrison S，et al.Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease.J Hepatol，2014，60（1）：167-174 dd+Wxez3uONfZfOXZEGXQCmsk0ZoQbqRVJER/K9AeVwJYYKJL22fVTbYK9PCZebJ